[1]
“Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies”, Drug Discov. Development, vol. 2, no. 1, pp. 1–16, Apr. 2026, doi: 10.5530/ddd.2.1.1.